Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Astatine (211At) as a therapeutic radionuclide. The plasma:blood cell distribution in vitroT C RichardsonCancer Detection and Prevention|January 1, 1982
Biological markers in lung cancer: an immunocytochemical approachE Heyderman, D V Chapman, T C RichardsonJournal of Clinical Pathology|December 1, 1984
Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphataseE Heyderman, B M Brown, T C RichardsonJournal of Clinical Pathology|April 1, 1983
Immunoperoxidase techniques: the deleterious effect of sodium azide on the activity of peroxidase conjugatesT C Richardson, D V Chapman, E HeydermanHistochemistry|January 1, 1987
The immunohistochemical demonstration of thyroglobulin in human thyroid tumour xenografts using a monoclonal antibodyT C Richardson, S A Humm, T E CarrBritish Journal of Experimental Pathology|June 1, 1987
Subcutaneous implantation of double velour Dacron into the mouse: infiltration and angiogenesisT C Richardson, J A Humphreys, K M TownsendCancer|December 1, 1985
Human chorionic gonadotropin and human placental lactogen in extragonadal tumors. An immunoperoxidase study of ten non-germ cell neoplasmsE Heyderman, D V Chapman, T C Richardson, et al.British Journal of Cancer|November 1, 1986
Characterisation of a new murine B cell lymphomaL M Cobb, M J Glennie, H M McBride, et al.Histopathology|May 1, 1984
Epithelial markers in primary skin cancer: an immunoperoxidase study of the distribution of epithelial membrane antigen (EMA) and carcinoembryonic antigen (CEA) in 65 primary skin carcinomasE Heyderman, R M Graham, D V Chapman, et al.British Journal of Cancer|September 1, 1985
A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2E Heyderman, I Strudley, G Powell, et al.Pageof 2